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Myelin facilitates the fast transmission of nerve impulses and provides metabolic support
to axons. Differentiation of oligodendrocyte progenitor cells (OPCs) and Schwann cell
(SC) precursors is critical for myelination during development and myelin repair in
demyelinating disorders. Myelination is tightly controlled by neuron-glia communication
and requires the participation of a wide repertoire of signals, including neurotransmitters
such as glutamate, ATP, adenosine, or γ-aminobutyric acid (GABA). GABA is the main
inhibitory neurotransmitter in the central nervous system (CNS) and it is also present in
the peripheral nervous system (PNS). The composition and function of GABA receptors
(GABARs) are well studied in neurons, while their nature and role in glial cells are still
incipient. Recent studies demonstrate that GABA-mediated signaling mechanisms play
relevant roles in OPC and SC precursor development and function, and stand out the
implication of GABARs in oligodendrocyte (OL) and SC maturation and myelination.
In this review, we highlight the evidence supporting the novel role of GABA with an
emphasis on the molecular identity of the receptors expressed in these glial cells
and the possible signaling pathways involved in their actions. GABAergic signaling
in myelinating cells may have potential implications for developing novel reparative
therapies in demyelinating diseases.
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INTRODUCTION
Glial cells express a vast repertoire of receptors and transporters for neurotransmitters and
neuromodulators and respond to axonal signals, being key and active elements of the nervous
system (Allen and Lyons, 2018). In vertebrates, oligodendrocytes (OLs) and Schwann cells
(SCs) are the myelin-forming glia of the central nervous system (CNS) and peripheral
nervous system (PNS), respectively. These cells are responsible for myelin building and
maintenance, a function highly regulated by neuronal activity (Gibson et al., 2014; Mitew
et al., 2018). Myelin speeds up nerve impulse propagation and provides metabolic and
trophic support to axons (Nave and Trapp, 2008; Kidd et al., 2013; Philips and Rothstein,
2017). Thus, myelination represents the major function of these cells, although they carry
it out with some differences; while OLs can myelinate multiple axons simultaneously, each SC
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wraps one single axon (Jessen andMirsky, 2005; Nave and Trapp,
2008). Regarding their specific characteristics, oligodendroglial
cells represent a highly diverse and specialized cell population
(Marques et al., 2016). Mature myelinating OLs develop
from glial precursors named oligodendrocyte progenitor cells
(OPCs), which constitute the main proliferating cell type in
the adult CNS (Dawson et al., 2003). On the other hand, SCs
derive from SC precursors, which differentiate into immature
SCs. These immature SCs can generate both myelinating
and non-myelinating SCs (or Remak glia) according to PNS
requirements, like the presence of specific signals in the
microenvironment and the diameter of axons in their vicinity
(Jessen and Mirsky, 2005, 2019; Kidd et al., 2013).
Differentiation of OPCs and SC precursors is necessary for
remyelination in demyelinating diseases like multiple sclerosis
(MS) and myelin formation in dysmyelinating diseases such as
leukodystrophies in the CNS or Charcot-Marie Tooth in the PNS.
In this regard, understanding the mechanisms of action involved
in this complex neuron-glia crosstalk will help us in the search
for new therapeutic approaches in these pathologies.
Neuronal activity and several signals such as transcriptional
and growth factors, axonal ligands, hormones, extracellular
matrix components or neurotransmitters regulate OPC/SC
precursor differentiation and myelination. Among them,
GABAergic signaling has attracted great interest in the last years
(Procacci et al., 2013; Zonouzi et al., 2015; Arellano et al., 2016;
Hamilton et al., 2017; Serrano-Regal et al., 2020).
GABA, which is present both in the CNS and PNS, exerts
an excitatory role during development to modulate neuronal
growth and synapse formation (Ben-Ari, 2002). It acts mostly
through ionotropic GABAA (GABAARs) and metabotropic
GABAB receptors (GABABRs) that are well described in neurons
but not yet fully characterized in myelinating cells. Although the
expression of GABA receptors (GABARs) in OL/SC precursor
lineages is widely documented (von Blankenfeld et al., 1991;
Williamson et al., 1998; Magnaghi et al., 2004; Luyt et al., 2007;
Arellano et al., 2016; Serrano-Regal et al., 2020), their role in
differentiation and myelination is a matter of ongoing research.
In this review, we recapitulate recent evidence about
GABAA and GABAB receptor expression and function in
oligodendroglial and SCs, together with the implication of
the GABAergic signaling in OPC/SC differentiation and
myelination. Furthermore, we discuss possible signaling
pathways involved in these events and their relevance
to develop new therapies to treat demyelinating and
dysmyelinating diseases.




GABAARs are integral membrane ion channels—permeable
to Cl− and HCO3− anions—composed of five subunits that
mediate the major form of fast inhibitory neurotransmission
in the CNS (Olsen and Sieghart, 2008; Doyon et al., 2016).
There are, at least, 19 distinct GABAAR subunit genes, which
include 6 α (α1-α6), 3 β (β1-β3), 3 γ (γ1-γ3), 3 ρ (ρ1-
ρ3), and 1 gene of the respective δ, ε, θ, and π subunits
(Sieghart and Savić, 2018). This diversity results in different
homomeric or heteromeric subunit combinations that may have
specific locations in the CNS, particular pharmacology, and,
consequently, distinctive functional characteristics (Vogt, 2015).
The subunit profile that forms GABAARs depends on several
factors including brain region, cell type, developmental stage, and
physiological or pathophysiological conditions (Levitan et al.,
1988; Seeburg et al., 1990; Waldvogel and Faull, 2015). Currently,
11 GABAAR subtypes with different subunit combinations have
been identified, being most of them heteromeric receptors
formed by αxβxγx or αxβxδ (where x represents any subtype
of a given subunit; Figure 1A), whereas others are homomeric
receptors formed by ρ subunits (Barnard et al., 1998).
Oligodendroglial Cells
Activation of GABAARs is relevant for the modulation of
myelinating cell physiology (Magnaghi, 2007; Vélez-Fort et al.,
2012), however, the specific subunit composition of GABAARs
expressed in these cells remains unknown. Electrophysiological
recordings in OPCs and OLs reveal differences between the
response of the GABAAR expressed in these cells and those
expressed in neurons and astrocytes (Table 1), suggesting
the presence of a novel GABAAR subtype with unique
stoichiometry in the oligodendroglial lineage (von Blankenfeld
et al., 1991; Williamson et al., 1998; Vélez-Fort et al., 2012;
Arellano et al., 2016).
von Blankenfeld et al. (1991) suggested that GABAARs in
murine OPCs and OLs carry a γ subunit required to form the
benzodiazepine binding site, as they observed potentiation of
the GABA response in these cells with classic benzodiazepines.
Moreover, the inverse agonist β-carboline methyl 4-ethyl-6,7-
dimethoxy-9H-β-carboline-3-carboxylate (DMCM) reduced the
GABA-induced current responses in oligodendroglial cells,
unlike what happens in astrocytes. Contrary to that, Williamson
et al. (1998) reported no influence of flunitrazepam or DMCM in
the response elicited by GABA in rat-derived OPCs, indicating
an absence of the γ subunit in the GABAARs expressed by
these cells. This observation was supported by the inhibitory
effect of Zn2+, which is characteristic of receptors that lack the
γ2 subunit. RT-PCR analyses conducted in the same study did
not find expression of γ2, α1, α6, and δ subunit mRNAs in OPCs.
Although amplification of other subunits was demonstrated, the
results were interpreted with caution since the preparation was
85% pure for OPCs and the presence of GABAARs from other
cell types could not be excluded. In a third study conducted by
Bronstein et al. (1998), the GABA response of an immortalized
murine glial cell line that expresses mature myelin proteins was
insensitive to diazepam and sensitive to Zn2+, reinforcing the
idea of γ-subunit absence.
Later, Passlick et al. (2013) reported the expression of two
types of GABAARs in hippocampal NG2 cells from juvenile
mice by functional and pharmacological analyses and single-cell
RT-PCR. NG2 cells from this brain area express, on the one
hand, postsynaptic GABAARs comprised of a combination of
α1, α2, β3, γ1, and γ2 subunits and, on the other hand, they
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FIGURE 1 | GABAAR expression in myelinating cells. (A) There are 11 different GABAAR subtypes described, mainly heteromeric receptors with αxβxγx or αxβxδ
(where x represents any subtype of a given subunit) stoichiometry (Olsen and Sieghart, 2008). Among them, a single type of GABAAR appears to be present in
oligodendrocytes though its molecular nature remains elusive. (B) Recent evidence using gene expression and pharmacology shows that GABAARs in
oligodendroglia are heterogeneous and may change in subunit composition during differentiation. Thus, at least two novel subtypes were identified: one formed by a
combination of α1 or α2, β3, and γ2 subunits (Passlick et al., 2013) and another made up by α3, β2 or β3, and γ1 or γ3 subunits (Arellano et al., 2016). (C) In turn,
studies using RT-PCR and/or immunohistochemistry conclude that SCs express high levels of α2, α3, β1, β2, and β3, while α1, γ1, and γ2 levels are relatively low in
these cells (Magnaghi et al., 2006).
have extrasynaptic GABAARs mostly lacking the γ2 subunit
(Figure 1B).
Our studies of GABAAR responses conducted in cultured
immature OLs from the rat forebrain and mature OLs from
the optic nerve showed that these cells are diazepam-sensitive,
suggesting once more the presence of a γ subunit (Arellano
et al., 2016). This positive modulation by benzodiazepines
was observed when using low GABA concentrations (≤EC30),
which may explain the discrepancies with previous studies.
Concerning the specific subtype of γ subunit, two observations
indicate that γ2 may not contribute to oligodendroglial
GABAARs: (1) Zn2+ blocks GABA responses; and (2) indiplon,
a positive allosteric modulator acting on γ2 subunit-containing
receptors, does not modulate GABA currents. Therefore,
these receptors likely contain either γ1 or γ3 subunit
(Arellano et al., 2016).
Regarding β subunits, potentiation of the GABA response
by loreclezole suggests the presence of β2 or β3 subunits, since
β1 subunit-containing receptors are insensitive to this drug
(Arellano et al., 2016). Finally, concerning α subunits, α3 is
the most likely candidate because it forms receptors with low
sensitivity to GABA (Karim et al., 2013), as it is the case of OLs
(EC50 between 70 and 100 µM).
Together, these pharmacological studies suggest that
the composition of the GABAAR expressed in rat-derived
oligodendroglial cells is a combination of the α3, β2 or β3,
and γ1 or γ3 subunits (Figure 1B). Also, we confirmed the
expression of the α3 subunit by immunocytochemistry in
cultured OLs (Arellano et al., 2016). These observations are
supported by previous functional genomic analyses performed
in OLs (Cahoy et al., 2008). Moreover, RNA sequencing (RNA-
Seq) transcriptional analyses of purified NG2 cells obtained from
P17 mice revealed that the α3 subunit is the most expressed
α-subtype, while among β subunits, β3 and β2 are much more
abundant than β1. Lastly, γ1 is expressed at much higher levels
than γ2 and γ3 (Larson et al., 2016).
An important factor for the diversity of GABAARs
expressed and the subunits involved in their conformation
will undoubtedly be the species. For example, regarding
humans, a recent study of the GABAAR-subunit expression
in OPCs isolated from the middle temporal gyrus of healthy
adults—based on the single-nucleus RNA-Seq analysis by Hodge
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TABLE 1 | Pharmacological properties of neuronal and oligodendroglial GABAARs.
Neurons
Drug Synaptic (αxβxγ2) Extrasynaptic (αxβxδ) Oligodendroglial cells
GABA Low EC50 1–30 µM Low EC50 0.5 nM–10 µM High EC50 70–100 µM
(Gibbs et al., 1996; Baur and Sigel,
2003; Mortensen et al., 2012)
(Brown et al., 2002; Wallner et al.,
2003; Mortensen et al., 2012)
(Williamson et al., 1998; Arellano
et al., 2016)
THIP No effect + No effect
(Mortensen et al., 2010) (Brown et al., 2002; Meera et al.,
2011)
(Arellano et al., 2016)
Zn2+ Low or No effect − −
(Hosie et al., 2003) (Carver et al., 2016) (Bronstein et al., 1998; Passlick
et al., 2013; Arellano et al., 2016)
β-CCB − or No effect No effect +
(Peña et al., 1986;
Cisneros-Mejorado et al., 2020)
(Jiménez-González et al., 2011) (Arellano et al., 2016;
Cisneros-Mejorado et al., 2020)
DMCM − − −
(Peña et al., 1986) (Brown et al., 2002) (von Blankenfeld et al., 1991;
Arellano et al., 2016)
Diazepam + No effect +
(Walters et al., 2000; Goodkin and
Kapur, 2009)
(Goodkin and Kapur, 2009) (von Blankenfeld et al., 1991;
Passlick et al., 2013; Arellano et al.,
2016)
Indiplon + No effect No effect
(Petroski et al., 2006) (Michelsen et al., 2007) (Arellano et al., 2016)
Flunitrazepam + No effect +
(Goodkin and Kapur, 2009) (Goodkin and Kapur, 2009) (von Blankenfeld et al., 1991;
Arellano et al., 2016)
Loreclezole +* +* +
(Wingrove et al., 1994) (Wingrove et al., 1994) (Arellano et al., 2016)
(+) Potentiator/agonist; (−) Inhibitor; (*) β2 or β3 subunit required.
et al. (2019)—showed that OPCs from this brain area express
high mRNA levels of α3, all β subunits, γ2 and, interestingly,
the ε subunit (Figure 2). These mRNAs, if translated and
incorporated into functional receptors, would increase the
variety of potential configurations and may have important
functional and pharmacological consequences (Jones and
Henderson, 2007; Bollan et al., 2008; Belujon et al., 2009).
Schwann Cells
GABAA-type receptors are relevant to SC physiology (Magnaghi
et al., 2001, 2006). However, their pharmacological and
functional properties, as well as their molecular identity, are not
clear. GABAAR subunit composition in rat-derived cultured SCs
includes α2 and α3, as well as the three β subunits, while mRNAs
of α1 and γ2 subunits have been found at much lower levels
(Magnaghi et al., 2006; Figure 1C). Moreover, the presence of α2,
α3, and β3 proteins were confirmed by immunocytochemistry.
Alpha-2 and β3 subunits are also expressed in SC-like adult
stem cells derived from bone marrow or adipose tissue, as
their levels are upregulated following SC differentiation in vitro
(Faroni et al., 2012). Also, GABAAR stimulation with muscimol
increases the proliferation rate of SCs, meaning that GABAergic
signaling has an important role in these cells (Magnaghi et al.,
2006). However, despite these important findings, there is still
little knowledge about the specific composition of GABAARs
expressed in differentiated SCs.
GABAB Receptors
GABABRs are G-protein coupled receptors (GPCRs) responsible
for the slower and prolonged GABA-mediated inhibitory
transmission. They were first described pharmacologically
as bicuculline-insensitive metabotropic receptors that were
activated by the GABA analog baclofen (Bowery and Hudson,
1979; Hill and Bowery, 1981). Functional GABABRs are
heterodimers constituted by two receptor subunits, GABAB1 and
GABAB2, that cooperate to perform signal activation (Kaupmann
et al., 1998; Kuner et al., 1999). GABAB1 is responsible for ligand
binding, while GABAB2 contains binding sites for allosteric
modulators (Galvez et al., 2001; Binet et al., 2004), couples with
Gi/o-protein, and is necessary for trafficking the heterodimer to
the cell surface, where the receptor becomes active (Calver et al.,
2000; Couve et al., 2000). Among the effector elements involved
in GABABR signaling pathways in neurons are voltage-gated
Ca2+ channels (VGCC), inwardly-rectifying potassium channels
(Kir) and adenylyl cyclase (AC; Bowery et al., 2002; Bettler et al.,
2004; Figure 3). However, the specific coupling of GABABRs to
the molecular effector may differ depending on the cell type and
region analyzed (Booker et al., 2018).
Oligodendroglial Cells
Myelinating cells express both subunits of GABABRs, which are
negatively-coupled to AC (Magnaghi et al., 2004; Luyt et al.,
2007). However, their functional characteristics are not as well
known as in the case of neurons. Regarding oligodendroglial
cells, we recently confirmed by immunocytochemistry and
RT-qPCR the expression of GABAB1 and GABAB2 subunits
in OPCs and OLs from the rat cerebral cortex and in OLs
from the optic nerve (Serrano-Regal et al., 2020). We also
performed calcium imaging assays and electrophysiological
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FIGURE 2 | The fractional contribution (FC) of GABAAR subunits in human
oligodendrocyte progenitor cells (OPCs). Normalized gene expression levels
for all 19 GABAAR subunits expressed as a percentage (mean ± S.E.M.) of
the total available pool of mRNA for GABAARs in OPCs (PDGFRα+ cells) from
human brains, estimated from publicly available datasets (Hodge et al., 2019;
https://celltypes.brain-map.org/rnaseq). The single-nucleus analysis used
normalized RNA-Seq datasets from the middle temporal gyrus isolated from
six subjects with no known neuropsychiatry or neuropathological history
(three males and three females; 35–66 years old). Gene expression level in
each dataset was transformed into FC (Sequeira et al., 2019). FC is defined
as the percentage of the expression level of each subunit gene (signaled in
the “y” axis) to the sum of the 19 genes for GABAARs subunits within each
human/cell. Detailed demographic characteristics, as well as technical white
papers for data processing and quality control, can be downloaded from the
same site. Confirmatory analysis of OPC markers enrichment and lack of
neuronal markers were performed for all datasets.
recordings in these cells and observed that baclofen does not
modify their response to KCl 50 mM, calcium influx, and
Kir currents. These results strongly suggest that GABABRs in
oligodendroglial cells are not coupled to Ca2+ and Kir channels
in the same manner as in other cell types (Serrano-Regal et al.,
2020). Likewise, GABABRs fromCA1 somatostatin interneurons,
unlike pyramidal neurons, are not coupled to the canonical
Kir3 signaling cascade (Booker et al., 2018), which suggests a
functional diversity of downstream effectors depending on cell
type and location, and warrants the need of exploring these
features in OLs as well as in SCs.
Charles et al. (2003) did not find any colocalization of
GABAB1 subunit and MBP expression in myelinating OLs
in the white matter of the rat spinal cord and suggested
that GABABR expression in developing OLs decreases during
differentiation. Following this, Luyt et al. (2007) observed
downregulation of the GABAB1 subunit in mature OLs from
the mouse periventricular white matter, while the expression
of GABAB2 remained constant. As they reported changes
in GABAB1/GABAB2 ratios in mature OLs, they raised the
possibility that one subunit alone or in combination with another
protein could make GABABR functional in different cell types
(Calver et al., 2000; Luyt et al., 2007). In contrast, our recent
results show that cultured oligodendroglial cells from the rat
forebrain and mature OLs from the optic nerve express GABAB1
and GABAB2 subunits at different stages of maturation, as well as
mature OLs from the juvenile and adult rodent corpus callosum
in vivo (Serrano-Regal et al., 2020). These discrepancies can be
explained by the different regions analyzed, as GABAB1/GABAB2
expression exhibits important regional variations (Luyt et al.,
2007). Since oligodendroglial cells are extremely diversified, the
different cells targeted in these studies may correspond to distinct
oligodendroglial and OPC subpopulations (Marques et al., 2016;
Spitzer et al., 2019; Marisca et al., 2020).
Schwann Cells
SCs also express different isoforms of the GABABR, such as -1a,
-1b, -1c, and -2 (Magnaghi et al., 2004, 2006).
Downregulation of GABABR expression occurs in pre-
and non-myelinating SCs (Corell et al., 2015). Neurosteroids
modulate the expression of GABABR subunits in cultured SCs
and, as GABABR is downregulated with age in the PNS, the
GABA synthesized in the adult sciatic nerve acts through
the ionotropic GABAAR, present both in neurons and SCs
(Magnaghi et al., 2006). Interestingly, the conditional knockout
of the GABAB1 subunit in SCs changes the expression of
GABAAR subunits α3, α4, β1, and δ (Faroni et al., 2019),
suggesting that GABABRs in these cells regulate somehow the
expression of GABAARs and/or their subunits.
Overall, more detailed analyses such as single-cell RNA-seq
would help to better figure out the expression of GABAB1 and
GABAB2 subunits along the oligodendroglial and SC lineages.
POTENTIAL GABA SYNTHESIS AND
RELEASE IN MYELINATING CELLS
Although GABAergic neurons are the main source of GABA
(especially in the CNS), GABA synthesis also occurs in glial cells
(Seiler et al., 1979; Angulo et al., 2008; Héja et al., 2012). Two
potential pathways for GABA synthesis have been described in
brain-derived glial cells. GABA is mainly produced through the
classical pathway as a result of glutamate decarboxylation by
the glutamic acid decarboxylase (GAD) enzymes (Roberts and
Frankel, 1950). In neurons, the two isoforms of GAD—GAD65
and GAD67—differ in their catalytic and kinetic properties
and their subcellular distribution (Kaufman et al., 1991).
Also, GABA can be synthesized from the monoacetylation
of putrescine with the participation of the monoamine
oxidase B (MAOB) enzyme in the non-classical pathway
(Seiler et al., 1973).
Consistent with an RNA-seq transcriptome and splicing
database (Zhang et al., 2014), oligodendroglial cells express
gad1, gad2, and maob mRNAs. GAD67 mRNA (gad1) is greatly
expressed by OPCs, although its levels decrease notably as they
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FIGURE 3 | Possible signaling pathways downstream GABARs leading to myelination. Activation of the Gi/o-linked GABABR may reduce CREB phosphorylation as
it is negatively coupled to adenylyl cyclase (AC; Luyt et al., 2007). Alternatively, it may also induce CREB phosphorylation possibly via activation of PLCβ/FAK/PKC or
MAPK cascades, as observed in neurons (Carlezon et al., 2005; Zhang et al., 2015). Moreover, activation of GABABR leads to Src phosphorylation (Serrano-Regal
et al., 2020) that could ultimately induce CREB activation. Phosphorylation of Src may also lead to Akt phosphorylation via PI3K as observed earlier (Barati et al.,
2015), and contribute to a positive feedback loop with p38MAPK (Mugabe et al., 2010; Lin et al., 2015), which is involved in myelination (Fragoso et al., 2003, 2007).
On the other hand, the GABAB1 subunit of GABABR might be sequestered by phosphatases like PP2A (as occurs in some neurons), a mechanism that blocks its
activity and can be reverted by high intracellular Ca2+ levels (Li et al., 2020). Finally, the GABAAR allosteric modulator ALLO regulates Schwann cell (SC) myelination
via Src-FAK signaling, involving cytoskeleton reorganization (Melfi et al., 2017).
differentiate into mature myelinating OLs. However, gad2 is
expressed to a lesser extent throughout the oligodendroglial
lineage. Regarding maob, OPCs and myelinating OLs express
higher levels than newly formed or immature OLs (Zhang et al.,
2014). Accordingly, we confirmed the presence of GAD65/67 by
immunocytochemistry and western blot in rat-derived cortical
oligodendroglial cells at 1, 3, and 6 days in vitro (Serrano-Regal
et al., 2020). Similarly, we verified the expression of the MAOB
enzyme in these cells at the same time points. These results
indicate that cultured oligodendroglial cells may synthesize
GABA by the two alternative pathways mentioned above. Indeed,
we found GABA immunostaining in cortical and optic-nerve
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derived oligodendroglial cells at different stages of maturation
(Serrano-Regal et al., 2020). Possibly, GABA is synthesized by
one pathway or another depending on the stage of maturation
of the cells, as GABA may have different roles in OPCs vs.
mature OLs.
GAD67 is present in SCs and its levels increase in the
presence of the progesterone metabolite allopregnanolone
(ALLO; Magnaghi et al., 2010). Moreover, Corell et al.
(2015) demonstrated the presence of GABA and GAD65/67 in
premyelinating and non-myelinating SCs. These findings show
that SCs both produce and store GABA.
Together, these observations indicate that OLs and SCs
synthesize and store GABA, which could be released by
reversal operation of GABA transporters including GAT-1 and
GAT-3, that are expressed by OLs (Fattorini et al., 2017;
Serrano-Regal et al., 2020). Also, SCs are capable to take
up ambient GABA at concentrations above 1 µM (Brown
et al., 1979), though the nature of the transporters involved is
still unknown.
GABA RECEPTORS IN OPC/SC
PRECURSOR DIFFERENTIATION AND
MYELINATION
In the CNS, OPCs are the main (but not unique) source of
remyelination, since they respond to white matter injury, migrate
to the lesioned area and differentiate into mature OLs to produce
new myelin sheaths (Franklin et al., 1997; Nait-Oumesmar et al.,
1999; Hesp et al., 2015). Moreover, surviving mature OLs are
also a source of remyelination (Duncan et al., 2018). SCs may
also participate, although to a lesser extent, in restoring myelin
in the CNS (Zawadzka et al., 2010; García-Díaz and Baron-Van
Evercooren, 2020).
Differentiation of OPCs/SCs and myelination are exquisitely
coordinated processes mediated by a deep dialogue between
neuronal and glial cells that entail the participation of a variety
of signals and intercellular communication systems, including
ATP, glutamate or GABA neurotransmitter signaling (Li et al.,
2013; Faroni et al., 2014; Salzer, 2015; Zonouzi et al., 2015;
Arellano et al., 2016; Hamilton et al., 2017; Serrano-Regal et al.,
2020), as well as neuronal activity (Wake et al., 2011; Gibson
et al., 2014; Fannon et al., 2015). Specifically, GABAergic neurons
establish direct synapses with OPCs throughout the CNS,
indicating that this communication may control proliferation,
migration, differentiation, the establishment of axonal contacts
and their wrapping, OPC survival in the adult brain or myelin
maintenance (Lin and Bergles, 2004; Kukley et al., 2008; Vélez-
Fort et al., 2010; Orduz et al., 2015; Zonouzi et al., 2015;
Balia et al., 2017; Mount et al., 2019). However, the precise
function of GABA in OPC differentiation and myelination
remains controversial.
GABAA Receptors
Contrary to mature neurons, activation of GABAARs in OPCs
leads to depolarization and an increase in cytosolic Ca2+ levels
(Kirchhoff and Kettenmann, 1992), resulting from Ca2+ influx
through activated VGCC (Paez and Lyons, 2020). Thus, a rise in
Ca2+ in the cytosol may regulate OPC proliferation, migration
and maturation and, consequently, OL (re)myelination (Cheli
et al., 2016; Santiago-González et al., 2017; Baraban et al., 2018;
Krasnow et al., 2018; Marisca et al., 2020).
As oligodendroglial cells constitute a highly dynamic
and heterogeneous population, the expression of GABAARs
and their different subunits changes as these cells progress
along their lineage, as occurs with the expression of certain
ion-channels (Spitzer et al., 2019), and these changes can
affect their intercellular relationship and differentiation. In
line with this, we observed that oligodendroglial GABAAR
expression in vitro is dependent on the close interaction
between axons and OLs, as OLs cultured alone lose GABA
responses with differentiation (Arellano et al., 2016). Moreover,
the presence of the γ2 subunit, which is associated with a
possible role in neuron-OPC synapse formation, decreases with
age along with the density of GABAergic synaptic contacts
in cortical NG2 cells of mature mice (Balia et al., 2015).
Thus, NG2 cells may switch the expression of GABAARs
from synaptic (with γ2 subunit) to extrasynaptic (without
γ2 subunit) during development (Vélez-Fort et al., 2010).
Surprisingly, genetic inactivation of oligodendroglial γ2 does
not affect OPC proliferation and differentiation, while it
causes progressive and specific depletion of the OPC pool
that lacks γ2-mediated synaptic activity without affecting
the oligodendrocyte production (Balia et al., 2017). These
observations indicate that GABAergic communication in
cortical OPCs through γ2-containing GABAARs does not
play a role in oligodendrogenesis but rather modulates
OPC maintenance.
GABAergic signaling regulates OPC population and OPC
differentiation and myelination in the cerebellar white matter
in vivo (Zonouzi et al., 2015). In turn, hypoxia causes a strong
downregulation of the GABAergic synaptic input from local
interneurons to OPCs (NG2 cells) as well as an increase in the
proliferation of these cells and a delay in their maturation, which
limits myelination. These effects are mimicked in control animals
when blocking GABAARs with their antagonist bicuculline.
However, they are reverted when applying tiagabine, a selective
inhibitor of the GABA transporter GAT-1 that increases GABA
availability in the extracellular space. Treatment with tiagabine
results in a decrease of NG2 cell proliferation and an increase of
myelinating OLs, reverting the hypomyelinating effect caused by
perinatal hypoxia (Zonouzi et al., 2015). These findings strongly
suggest that GABAergic signaling (either neuronal activity-
dependent or independent) influences OPC development
and differentiation and, therefore, it may help to develop
novel therapies to improve OPC differentiation into damaged
brain areas.
GABAergic signaling through GABAARs may also be relevant
for the stronger remyelination that occurs following focal
demyelination in the corpus callosum of late pregnant rats
compared to virgin and postpartum ones (Kalakh and Mouihate,
2019). This pregnancy-associated promyelinating effect was lost
when either the GABAAR was blocked or when 5α-reductase,
the rate-limiting enzyme for the endogenous GABAAR activator
ALLO, was inhibited (Kalakh and Mouihate, 2019). Moreover,
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N-butyl-β-carboline-3-carboxylate (β-CCB), a selective drug
activating preferentially oligodendroglial GABAARs, promotes
remyelination in a model of gliotoxin-induced demyelination
in the rat cerebellar caudal peduncle as assessed using
magnetic resonance imaging (MRI) together with myelin
staining (Cisneros-Mejorado et al., 2020). Together, these results
strongly suggest that GABAAR-mediated signaling promotes
myelination and remyelination in OLs either directly or
indirectly. However, at odds with these data, activation of
GABAARs by endogenous GABA in cortical organotypic cultures
reduces the number of oligodendroglial cells and myelination
whereas enlarges internode length, influencing the velocity of
the nerve impulse propagation (Hamilton et al., 2017). These
effects may be due to GABA released by glial cells. However,
we could not assess this idea as gabazine treatment of OPC
cultures had no significant effect on myelin protein production
(Serrano-Regal et al., 2020).
Neurosteroid therapy is another pharmacological approach
to modulate GABAAR activity in the nervous system, as they
act as allosteric modulators of these receptors in the nanomolar
concentration range (Lambert et al., 2009). Indeed, progestin
ALLO increases myelin basic protein (MBP) production in
rat-derived cerebellar organotypic slices, an effect that requires
GABAARs (Ghoumari et al., 2003). This observation points
to these receptors as mediators of myelination. The effects of
neurosteroids are of special interest in postnatal development,
as they may help to prevent neurodevelopmental disorders
associated with preterm birth (Shaw et al., 2019). ALLO, which is
mainly synthesized in the placenta, has an important role during
nervous system development. In premature neonates, ALLO
concentration decreases abruptly and this decrease is associated,
in part, with hypomyelination (Shaw et al., 2015). Consequently,
experimental administration of the ALLO analog ganaxolone
as replacement therapy in guinea pig-preterm neonates showed
positive effects on myelination, through its interaction with
GABAARs. Therefore, neurosteroid replacement could be a good
therapeutic option to improve myelination in this condition
(Shaw et al., 2019).
Neurosteroids may also enhance GABAAR function in
SCs. Thus, ALLO acting via GABAA receptor can influence
peripheral myelin protein 22 (PMP22) synthesis (Magnaghi et al.,
2006). Moreover, ALLO modulates SC morphology, motility,
and myelination in SC/dorsal root ganglia neuron (DRG)
co-cultures via the Src/focal adhesion kinase (FAK) pathway,
a signaling cascade that involves GABAARs and relies on actin
rearrangements (Melfi et al., 2017). Therefore, neurosteroids
represent a promising molecular approach for the treatment
of peripheric pathologies. Together, the studies discussed
in this section connect GABAAR signaling with OPC/SC
differentiation and/or myelination using pharmacological
approaches. However, the results observed cannot be solely
attributed to the action of GABA on GABAARs. Although
pharmacology may be a good strategy to enhance OPC/SC
differentiation and myelination in pathological conditions,
potential side-effects must also be considered. To minimize
them, it would be of great interest to use more specific drugs
acting on myelinating cell GABAARs and/or to use genetic
approaches to specifically target the different GABAAR subunits
expressed in these cells.
GABAB Receptors
An early study suggests that GABABRs may be relevant for OPC
development as baclofen increases migration and proliferation in
cultured OPCs derived from periventricular white matter (Luyt
et al., 2007). However, more recent studies could not confirm
those findings as baclofen did not change OPC proliferation
or total OPC number in dissociated and organotypic cultures
derived from the cortex (Hamilton et al., 2017; Serrano-Regal
et al., 2020). This discrepancy could reflect the different brain
areas studied. Thus, different subpopulations of OPCs may
exist in white and gray matter that behave differently or have
different responses to baclofen, as proposed by Luyt et al. (2007).
In contrast, baclofen reduced cell proliferation of SC cultures
(Magnaghi et al., 2004). However, in dissociated developing DRG
primary cultures, in which SCs proliferate spontaneously in vitro,
baclofen did not affect (Corell et al., 2015).
On the other hand, GABA and baclofen modulate OPC
differentiation, as well as the myelination capacity of mature OLs
cultured with DRG neurons, pointing out GABABRs as relevant
modulators of OL maturation and myelination (Serrano-Regal
et al., 2020). Consistent with these observations, GABABRs
also regulate SC differentiation both in the myelinating
and non-myelinating phenotypes. Thus, forskolin-induced
SC differentiation in vitro correlates with a redistribution
of GABAB1 and GABAB2 subunits of GABABRs. Indeed,
in the cytoskeleton rearrangement that takes place during
differentiation, GABABRs colocalize with f-actin on the SC
elongated processes (Procacci et al., 2013).
Apart from being essential for SC commitment to a
non-myelinating phenotype during development, GABABRs
are key modulators of neuronal-SC interactions regarding
myelination, as GABAB1 receptor total null mice showed altered
levels of PMP22 and myelin protein zero (P0) as well as thinner
myelin sheaths. These mice also presented fiber alterations,
which causes changes in pain behavior, gait abnormalities,
and motor coordination disturbances (Magnaghi et al., 2008).
Together, these findings suggest a role for GABABRs in the
control of SC myelination. Moreover, both GABABR subunits
in addition to GABA and GAD65/67 were found at the node of
Ranvier in a sub-population of myelinated sensory fibers (Corell
et al., 2015). Surprisingly, GABABR expression is upregulated in
SCs of injured nerves, which may be interpreted as an adaptive
response for stimulating the neighboring axons to re-grow
distally to the injury (Corell et al., 2015).
Finally, conditional deletion of the GABAB1 subunit in SCs
altered their proliferation, migration, and myelination capacities,
as well as reduced neurite length of co-cultured DRGs (Faroni
et al., 2019). Furthermore, molecular and transcriptomic changes
were also observed both in SCs and DRGs derived from mice
lacking GABAB1 subunit in SCs (P0-GABA-B1fl/fl). Interestingly,
the expression of some GABAAR subunits by SCs and DRGs
was also altered, indicating a possible role of GABABRs in
regulating the expression of GABAARs in these cells (Faroni et al.,
2019). Similar studies using conditional deletion of GABABR
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subunits in oligodendroglia will help to understand the role of
these receptors and their impact on myelination and pain and
motor behavior.
POSSIBLE SIGNALING PATHWAYS
DOWNSTREAM GABARs RELATED TO
MYELINATION
Myelination, either by OLs or SCs, involves the participation
of several intracellular signaling pathways. Indeed, some
of those pathways are common in the CNS and PNS. For
instance, binding of neuregulins (NRGs) to ErbB receptors
activates a sequence of canonical intracellular pathways
downstream from many receptor tyrosine kinases (RTKs), such
as phosphatidylinositol-3-kinase (PI3K)/Akt/mammalian target
of rapamycin (mTOR) or mitogen-activated protein kinases
(MAPK; Newbern and Birchmeier, 2010).
Intracellular 3′,5′-cyclic adenosine monophosphate (cAMP)
induces cell differentiation and myelination requiring the
participation of the cAMP response element-binding protein
(CREB). CREB mediates the stimulation of MBP expression by
cAMP in OLs (Afshari et al., 2001). Moreover, in mouse-derived
cultured SCs, the combined action of cAMP/NRG1 increases
the expression of myelin proteins Krox-20 and P0, through a
mechanism that relies on the activity of transcription factors
from the CREB family (Arthur-Farraj et al., 2011).
The Src family kinases (SFKs) are nonreceptor tyrosine
kinases that integrate external signals from both integrin and
growth factor receptors and transduce signals related to OL and
SC development and myelination (Colognato et al., 2004; Melfi
et al., 2017). In particular, signaling pathways downstream the
Src-family member Fyn regulate morphological differentiation
of OLs, the recruitment of cytoskeleton components, and
local translation of MBP (see White and Krämer-Albers, 2014;
Quintela-López et al., 2019). GABABR specific activation with
baclofen induces Akt phosphorylation, which is dependent on
PI3K and Src kinases, promoting chemotaxis and cytoskeletal
rearrangement in rat basophilic leukemic cells (Barati et al.,
2015). Accordingly, we found that Src-family kinases inhibition
abrogates GABABR-induced OL differentiation (Serrano-Regal
et al., 2020). This observation corroborates the role of the Src
family in OL differentiation through a mechanism dependent on
GABABR activation (Figure 3).
GABAARs are also linked to Src and FAK signaling.
The modulation of SC development and myelination by the
neurosteroid ALLO in SC/DRG co-cultures occurs via Src and
FAK signaling activation, which depends on GABAARs and actin
reorganization (Melfi et al., 2017). Besides, Src-family members
can interact reciprocally with kinases from theMAPK family, like
the serine/threonine-protein kinase p38 MAPK, as c-Src elicits
p38 MAPK phosphorylation and the opposite (Mugabe et al.,
2010; Lin et al., 2015; Wu et al., 2015). Therefore, it would
be of great interest to investigate this kind of interactions in
myelinating cells, as p38 MAPK is a key element in the initial
steps of myelination in SCs (Fragoso et al., 2003), as well as
in OL maturation and myelination since specific p38 inhibitors
block in vitromyelination of DRGs by OLs (Fragoso et al., 2007).
Also, conditional knockout of p38 in oligodendroglial cells leads
to defects in myelination early in development (Chung et al.,
2015). At odds with those findings, deletion of p38 in the same
mouse model increases remyelination after cuprizone-induced
demyelination (Chung et al., 2015), while selective deletion of
p38αMAPK in OLs did not compromise myelination in a mouse
model of periventricular leukomalacia (PVL; Chung et al., 2018).
These conflicting pieces of evidence indicate that the precise role
of p38 MAPK in SC/OL differentiation and myelination and its
relation with GABARs remains to be elucidated (Figure 3).
Since GABABRs couple negatively to AC in OLs (Luyt
et al., 2007), activation of CREB downstream these receptors
is not expected due to decreased cAMP levels. However, other
intracellular signaling cascades activated downstream G-protein
coupled receptors, such as MAPK cascades, may phosphorylate
CREB (see Carlezon et al., 2005). Thus, GABABR stimulation
in cultured mouse cerebellar granule neurons with baclofen
activates CREB via PLCβ/FAK/PKC (Zhang et al., 2015). Further
clarification of the link between GABABR activation and CREB
specifically in myelinating cells is a matter of ongoing study and
could contribute to a better understanding of the signaling routes
that control myelination and remyelination (Figure 3).
Finally, GABABR function may be modulated by its direct
association to protein phosphatase 2A (PP2A), as observed in
GABAergic neurons from the rodent ventral tegmental area (Li
et al., 2020). Therefore, PP2A-GABABR interaction results in
an increase of GABABR dephosphorylation and its subsequent
internalization, an effect reverted with high intracellular Ca2+
levels. Again, it is worth exploring if these mechanisms also occur
in myelinating cells and whether they are relevant to myelin
pathology (Figure 3).
DISCUSSION
GABA is among the signals that drive OLs and SCs to axon
interactions. The fact that GABA acts mainly on two different
types of receptors—ionotropic GABAARs and metabotropic
GABABRs—makes it difficult to understand the role of this
neurotransmitter in myelinating cell physiology. Moreover, OLs
and SCs are highly dynamic cell lineages with different stages
of maturation.
While the molecular composition of both GABARs and
their mechanisms of action are well described in neurons,
their properties in myelinating glial cells remain elusive. Native
GABAARs are composed of multiple subunit combinations
with diverse pharmacology, both of which vary regionally,
adding a huge heterogeneity to their properties and functions.
This diversity is also reflected somehow in GABAARs in
OLs and SCs. Thus, SCs express extra-synaptic subunits (in
particular the δ subunit, which is key for neurosteroid affinity),
while OLs express subunits commonly found at postsynaptic
densities, meaning that GABAARs of OLs and SCs have
different subunit composition and, consequently, different
pharmacological profiles and functional behaviors (Faroni et al.,
2019). Also, there is a switch in the expression of synaptic to
extrasynaptic GABAARs as OPCs progress in the lineage (Vélez-
Fort et al., 2010; Balia et al., 2017).
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FIGURE 4 | Effects of GABAergic signaling in oligodendroglial differentiation and myelination. OPCs express GABAA and GABABRs. Activation of GABAARs causes
depolarization in these cells (Kirchhoff and Kettenmann, 1992; Baraban et al., 2018). In absence of axons (top), they lose GABAAR expression as they differentiate
into mature OLs (Berger et al., 1992; Arellano et al., 2016); however, expression of GABABRs is largely stable over time (Serrano-Regal et al., 2020). In the presence
of axons (low), GABAAR expression is modulated by neurons, as OPCs maintain their expression towards the myelinating stage (Arellano et al., 2016). Moreover,
oligodendroglial cells express GAT-1 transporter and synthesize GABA, which may be released by reverse GAT-1 operation and activate GABA receptors (GABARs)
in an autocrine manner. Exogenous GABA or baclofen promotes oligodendroglial differentiation and myelination in vitro (Serrano-Regal et al., 2020).
In oligodendroglial cells, GABAAR expression goes down
as they mature and acquire a myelinating phenotype (Berger
et al., 1992; Arellano et al., 2016). In contrast, GABABR
expression is quite stable at all stages (Serrano-Regal et al.,
2020). Sustained GABAAR expression in oligodendroglial cells
depends on the presence of axons, though the mechanisms
driving GABAAR stabilization remain still unknown. Thus, it
is likely that molecules released from neurons in an activity-
independent manner may drive GABAAR expression (Arellano
et al., 2016; Hamilton et al., 2017; Figure 4).
Also, OLs and SCs can synthesize and store GABA, and
to take it up from the extracellular fluid through specific
GABA transporters (Fattorini et al., 2017). It is therefore
conceivable that these cells may release GABA by mechanisms
including reverse functioning of the transporters, as observed
in other glial cell types (Barakat and Bordey, 2002). Early
experiments demonstrated that cultured satellite glial cells from
DRG can release [3H]GABA in response to a depolarizing
stimulus (Minchin and Iversen, 1974). Thus, GABA released
by myelinating cells might act in a paracrine or autocrine
way (as suggested by Magnaghi, 2007) to, ultimately,
modulate their differentiation and/or their myelination
capacity (Figure 4). Interestingly, this mechanism operates
for instance in polysialylated forms of neural cell-adhesion
molecule (PSA-NCAM) progenitor cells in the CNS, which
eventually differentiate into glial cells. Thus, autocrine/paracrine
loops involving neurosteroids and GABA signaling in these
progenitors modulate their proliferation and differentiation
(Gago et al., 2004). Synthesis of neurosteroids occurs in
SCs (Chan et al., 2000), and may stimulate GABA synthesis
in these cells via a rapid protein kinase A (PKA)-dependent
autocrine loop (Magnaghi et al., 2010). In this way, neurosteroids
provide the specific ligand for GABAAR activation (Magnaghi
et al., 2010). As neurosteroids are involved in promoting SC
differentiation and myelination acting through GABAARs,
a possible paracrine/autocrine mechanism could underlie
these processes.
GABAA and GABAB receptors may exert opposite roles
on myelinating cells, as proposed for SCs in pathological
conditions (Faroni and Magnaghi, 2011). Both central and
peripheral myelinating cells express GABAA and GABAB
receptors, however, this expression depends on the presence
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of surrounding axons and, as occurs with other receptors and
transporters, may vary along the lineage or even depending on
the nervous system area (Marques et al., 2016; Spitzer et al.,
2019). Thus, depending on the developmental stage of these
cells and the GABAR involved, the neurotransmitter GABA may
play different physiological functions. Moreover, GABAergic
signaling could potentially regulate specific subgroups of cells
from the OL/SC lineages in different ways, either action-
potential dependently or independently. Thus, it appears that
in OPCs GABA acts mostly through GABAARs to carry out
some important functions at the progenitor level (as regulation
of the population size, OPC maintenance, axon-glia recognition,
differentiation or myelination initiation; Zonouzi et al., 2015;
Arellano et al., 2016; Balia et al., 2017; Hamilton et al., 2017;
Marisca et al., 2020).
Finally, GABABRs may contribute to myelin maintenance
(Figure 4). In this regard, GABARs may parallel somehow the
various functions played by glutamate receptors, as AMPARs
are crucial for the early stages of remyelination while NMDARs
are relevant for myelin maintenance and to fuel axonal function
(Lundgaard et al., 2013; Gautier et al., 2015; Saab et al., 2016).
In sum, understanding the contribution of the GABAergic
signaling to OL and SC physiology may be critical to find
therapeutic tools to improve remyelination in demyelinating
diseases. Meanwhile, it is necessary to clarify in detail the
role of GABA in OL and SC differentiation and myelination,
and the mechanisms that mediate these responses. To that
aim, it will be important to specifically target GABAARs and
GABABRs either at the progenitor stage or the more mature
stages of the myelinating cells. Drugs preferentially acting on
GABARs in OLs and SCs will certainly help to successfully tackle
these tasks.
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